<DOC>
	<DOCNO>NCT00435279</DOCNO>
	<brief_summary>To evaluate antidepressant effect adjunctive treatment Eszopiclone subject receive venlafaxine treatment Major Depressive Disorder ( MDD ) .</brief_summary>
	<brief_title>A Study Eszopiclone Co-administered With Venlafaxine Subjects With Major Depressive Disorder Insomnia</brief_title>
	<detailed_description>This double-blind , randomize , placebo-controlled , parallel-group study . The study consist two group subject Major Depressive Disorder randomize treatment either eszopiclone 3 mg placebo nightly bedtime 31 week begin night Visit 2 . In addition , subject receive open-label treatment venlafaxine . Safety efficacy evaluate use clinical observation well physician subject administer rating scale . This study previously post Sepracor Inc . In October 2009 , Sepracor Inc. acquire Dainippon Sumitomo Pharma. , October 2010 , Sepracor Inc 's name change Sunovion Pharmaceuticals Inc .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<criteria>Subjects must male female age 18 64 , inclusive , time signing consent . Subjects must primary diagnosis Major Depressive Disorder ( MDD ) DSMIV criterion ( 296.XX ) determine Mini International Neuropsychiatric Interview ( M.I.N.I. ) . MDD must condition chiefly responsible motivating subject seek treatment . Subjects must 17item Hamilton Depression Scale ( HAMD17 ) total score &gt; 22 screen visit . Subjects HAMD17 total score &lt; 18 Visit 2 discontinue study . All subject meet DSMIV criterion ( 307.42 ) Insomnia related Major Depressive Disorder . Subjects less total sleep time &lt; 6.5 hour least three time per week past month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Insomnia</keyword>
	<keyword>Depression</keyword>
	<keyword>Major Depressive Disorder</keyword>
</DOC>